Sutab Alternatives Compared
| Sutab | MiraLAX | Polyethylene glycol 3350 |
|
|---|
| Sutab (magnesium sulfate / potassium chloride / sodium sulfate) | MiraLAX (polyethylene glycol 3350) | Polyethylene glycol 3350 |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Bowel Preparation. Sutab may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for Irritable Bowel Syndrome with Constipation, Bowel Preparation, Constipation - Acute, Constipation, Irritable Bowel Syndrome. MiraLAX may also be used for purposes not listed in this... View more |
Prescription and OTC
Prescribed for Irritable Bowel Syndrome with Constipation, Bowel Preparation, Constipation - Acute, Constipation, Irritable Bowel Syndrome. polyethylene glycol 3350 may also be used for purposes not... View more |
Related suggestions Bowel Preparation
|
|||||||||||||||||||||||
| More about Sutab (magnesium sulfate / potassium chloride / sodium sulfate) | More about MiraLAX (polyethylene glycol 3350) | More about Polyethylene glycol 3350 | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Sutab has an average rating of 6.1 out of 10 from a total of 117 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 40% reported a negative effect. |
MiraLAX has an average rating of 7.2 out of 10 from a total of 259 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 23% reported a negative effect. |
Polyethylene glycol 3350 has an average rating of 7.1 out of 10 from a total of 342 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 24% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: Sutab side effects in more detail. |
See also: MiraLAX side effects in more detail. |
See also: polyethylene glycol 3350 side effects in more detail. |
||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Sutab prices |
View all MiraLAX prices |
View all polyethylene glycol 3350 prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Other polyethylene glycol 3350 brands include: ClearLax, GaviLAX, Gialax, GlycoLax, HealthyLax, PEG3350, Purelax, SunMark ClearLax | ClearLax, GaviLAX, Gialax, GlycoLax, HealthyLax, MiraLAX, PEG3350, Purelax, SunMark ClearLax View more | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Summary unavailable. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 538 drugs are known to interact with Sutab:
|
A total of 221 drugs are known to interact with MiraLAX:
|
A total of 221 drugs are known to interact with polyethylene glycol 3350:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
November 10, 2020 |
February 18, 1999 |
N/A |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.